当归芍药散对糖尿病认知障碍性疾病的研究进展  

Research Progress of Danggui Shaoyao San in Diabetic Cognitive Disorder

作　　者：常玉新[1] 张丹丹[1] 韩佳童 刘莹[2] 付新[2] CHANG Yuxin;ZHANG Dandan;HAN Jiatong;LIU Ying;FU Xin(Heilongjiang Hospital of Traditional Chinese Medicine,Harbin 150000,China;Heilongjiang University of Chinese Medicine,Harbin 150040,China)

机构地区：[1]黑龙江省中医医院,黑龙江哈尔滨150000 [2]黑龙江中医药大学,黑龙江哈尔滨150040

出　　处：《中医药学报》2021年第3期96-101,共6页Acta Chinese Medicine and Pharmacology

基　　金：国家自然科学基金面上项目(81973746);黑龙江省自然科学基金青年项目(QC2017114);黑龙江省教育厅优秀创新人才项目(UNPYSCT-2017222);黑龙江省中医药管理局科研项目(ZHY16-089);黑龙江省哈尔滨市科技局科研项目(2016RAQXJ214)。

摘　　要：经典古方当归芍药散最初记载于《金匮要略》,主要用于治疗妇科疾病。现代方剂学将其归入理血剂中,当归芍药散的临床使用范围已经大大拓宽。本文总结了当归芍药散治疗糖尿病认知障碍性疾病的研究,从其对胰岛素代谢,细胞凋亡,炎症损伤,糖尿病心肌病,雌激素的影响以及抗氧化作用,降血糖作用和对神经保护等方面进行了综述研究。The classic ancient prescription Danggui Shaoyao San was first recorded in Synopsis of the Golden Chamber for the treatment of gynecological diseases.Modern formulations classify it into blood management prescription.From the perspective of modern research,the clinical application scope of Danggui Shaoyai San has been greatly broadened.In this paper,the therapeutic effect of Danggui Shaoyao San on diabetic cognitive disorders has been reviewed in terms of its antioxidant effect,its influence on inflammatory damage and its neuroprotective effect.

关 键 词：糖尿病认知障碍 当归芍药散 胰岛素代谢 高血糖 

分 类 号：R255.4[医药卫生—中医内科学]